A Win For Tharimmune, Inc.

Mon, Aug 25, 2025 at 07:41 PM

Tharimmune, Inc. (THAR:NASDAQ) rocketted at $7.71, representing a gain of 63.3%. On Mon, Aug 25, 2025, THAR:NASDAQ touched a New 2-Week High of $7.71. The stock got featured on our News Catalysts scanner on Wed, Aug 20, 2025 at 10:55 AM in the 'EARNINGS' category. From Mon, Aug 11, 2025, the stock recorded 50.00% Up Days and 63.64% Green Days

About Tharimmune, Inc. (THAR:NASDAQ)

Hillstream BioPharma Inc is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron-mediated cell death for...

Top 10 Gainers:

Hempacco Co., Inc. (HPCO:NASDAQ), 350%
Inno Holdings Inc. (INHD:NASDAQ), 254.45%
Offerpad Solutions Inc. (OPAD:NYSE), 136.36%
OSR Holdings, Inc. (OSRH:NASDAQ), 96.12%
HeartCore Enterprises, Inc. (HTCR:NASDAQ), 76.55%
Wellgistics Health, Inc. (WGRX:NASDAQ), 73.55%
Tharimmune, Inc. (THAR:NASDAQ), 63.35%
HCW Biologics Inc. (HCWB:NASDAQ), 60.82%
DSS, Inc. (DSS:NYSEMKT), 49.27%
DarkIris Inc. (DKI:NASDAQ), 47.44%